NR4A1 and neoplasm: The tumor subtype influences the risk of recurrence, ranging from 13% to 41%, depending on the tumor and the state of the nodes of the primary tumor [76,77] as hormone receptor-positive, metastatic breast cancer, and triple-negative breast cancer.